A patient diagnosed with severe preeclampsia is exhibiting symptoms suggestive of HELLP syndrome. Which nursing action is the priority to address potential complications?

A) Administering magnesium sulfate to prevent seizures

B) Preparing the patient for potential early delivery

C) Monitoring liver enzyme levels and platelet counts closely

D) Educating the patient about the signs and symptoms of worsening preeclampsia

A patient with worsening preeclampsia is being considered for early delivery due to potential HELLP syndrome development. The healthcare team has initiated a magnesium sulfate infusion. What is the primary purpose of administering magnesium sulfate in this scenario?

C) To reduce the risk of seizures

A) To lower the patient's blood pressure

B) To prevent the progression of renal failure

C) To reduce the risk of seizures

A patient diagnosed with HELLP syndrome is receiving magnesium sulfate therapy. Despite this, her blood pressure remains elevated at 160/105 mmHg. The healthcare team is considering the addition of nifedipine to her treatment plan. Which nursing intervention is most important prior to administering nifedipine?

D) Confirm the availability of calcium gluconate at the bedside.

A) Ensure the patient has an adequate urinary output of at least 30 mL/hr.

B) Assess the patient's deep tendon reflexes for any changes.

C) Monitor the fetal heart rate for any signs of distress.

D) Confirm the availability of calcium gluconate at the bedside.

A patient with suspected HELLP syndrome is receiving magnesium sulfate and is being considered for nifedipine to manage persistent hypertension. Which nursing intervention is most critical in this scenario to prevent complications?

B) Encourage fluid intake to promote renal excretion of magnesium.

C) Administer calcium gluconate prophylactically to counteract magnesium.

D) Teach the patient to perform deep breathing exercises to reduce anxiety.

A pregnant patient with preeclampsia is showing signs of increased respiratory effort and mild bilateral pleural effusions. The fetal heart rate tracing indicates decreased variability and late decelerations. What is the most appropriate initial nursing intervention to prioritize maternal and fetal well-being?

B) Initiate oxygen therapy to improve maternal and fetal oxygenation

A) Administer a bolus of IV fluids to stabilize maternal blood pressure

B) Initiate oxygen therapy to improve maternal and fetal oxygenation

C) Prepare for immediate delivery to prevent further fetal distress

D) Increase the rate of magnesium sulfate infusion to prevent seizures

A patient with preeclampsia is showing signs of pulmonary edema and fetal distress. Which nursing intervention should be prioritized to address the immediate maternal and fetal risks?

B) Administer oxygen therapy to improve maternal oxygen saturation

A) Increase the infusion rate of intravenous fluids to maintain hydration

B) Administer oxygen therapy to improve maternal oxygen saturation

C) Position the patient in a supine position to enhance fetal circulation

D) Initiate tocolytic therapy to delay labor and allow further fetal maturation

A pregnant patient with preeclampsia is receiving magnesium sulfate for neuroprotection of the fetus and seizure prevention in the mother. The nurse notes that the patient's deep tendon reflexes are decreased. Which of the following actions should the nurse take next?

B) Administer calcium gluconate as an antidote to magnesium toxicity.

A) Continue to monitor the patient and reassess in 30 minutes.

B) Administer calcium gluconate as an antidote to magnesium toxicity.

C) Immediately discontinue the magnesium sulfate infusion.

D) Increase the frequency of vital signs monitoring to every 5 minutes.

A pregnant patient with preeclampsia is showing signs of progressing towards HELLP syndrome, with elevated liver enzymes and decreased platelet count. Her fetal monitoring indicates persistent late decelerations with minimal variability. Which nursing intervention is the priority at this time?

C) Administer magnesium sulfate as ordered to provide neuroprotection and manage maternal hypertension.

A) Increase the rate of oxygen delivery to improve maternal oxygenation.

B) Prepare the patient for an immediate cesarean section to address fetal distress.

C) Administer magnesium sulfate as ordered to provide neuroprotection and manage maternal hypertension.

D) Notify the healthcare provider to reassess the patient's blood pressure management plan.

A patient with severe preeclampsia is being treated with magnesium sulfate. Six hours after the initiation of treatment, the patient begins to exhibit diminished deep tendon reflexes and nausea. The magnesium level is reported at 9 mg/dL. What is the priority nursing action?

A) Administer calcium gluconate as ordered

B) Increase the rate of magnesium sulfate infusion

C) Reassess the patient's blood pressure

D) Place the patient in a left lateral position

A nurse is caring for a patient receiving magnesium sulfate for severe preeclampsia. After six hours, the patient exhibits signs of magnesium toxicity. What is the nurse's priority intervention?

B) Administer calcium gluconate as ordered and prepare for potential cesarean delivery.

A) Continue monitoring the patient and document the findings.

B) Administer calcium gluconate as ordered and prepare for potential cesarean delivery.

C) Increase the rate of magnesium sulfate infusion to counteract the symptoms.

D) Notify the healthcare provider about the fetal heart rate changes before taking any action.

preeclampsia - Nursing Case Study

Pathophysiology

• Primary mechanism: Placental ischemia due to abnormal trophoblastic invasion leads to poor remodeling of uterine spiral arteries, resulting in high-resistance, low-flow circulation and reduced placental perfusion.

• Secondary mechanism: Endothelial dysfunction triggered by placental factors leads to widespread vasoconstriction and increased systemic vascular resistance, contributing to hypertension and reduced organ perfusion.

• Key complication: Endothelial activation and injury cause capillary leakage and proteinuria, contributing to the hallmark sign of protein in urine and potential progression to severe complications like eclampsia or HELLP syndrome.

Patient Profile

Demographics:

28-year-old female, school teacher

History:

• Key past medical history: Gestational diabetes in previous pregnancy

• Current medications: Prenatal vitamins, Labetalol 200 mg twice daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache and visual disturbances

• Key symptoms: Swelling in hands and feet, upper abdominal pain, increased proteinuria

• Vital signs: Blood pressure 160/105 mmHg, heart rate 95 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

During the initial assessment, the healthcare team noted that the patient's persistent headache and visual disturbances had worsened overnight. Additionally, the patient reported nausea and a feeling of general malaise. A repeat blood pressure reading was elevated at 165/110 mmHg, indicating uncontrolled hypertension despite the current Labetalol regimen. Physical examination revealed increased swelling in the hands and feet, along with tenderness in the right upper quadrant of the abdomen. The patient's deep tendon reflexes were hyperreflexic, suggesting neurological irritability that raised concerns for potential progression to more severe preeclamptic complications.

Laboratory results were expedited, revealing a significant increase in proteinuria with a urine protein-to-creatinine ratio of 0.5, confirming worsening renal involvement. Liver function tests showed an elevation in liver enzymes, indicating hepatic stress, while platelet counts were slightly decreased but within the lower range of normal. These findings pointed to the possibility of HELLP syndrome development, necessitating close monitoring and potential adjustment in management strategy. The patient's hemoglobin and hematocrit levels were stable, and her renal function, though affected, had not yet reached critical levels, providing a temporary window for intervention.

Given the deteriorating clinical picture, the healthcare team decided to escalate monitoring and consider additional pharmacological intervention to manage the patient's hypertension more effectively. A magnesium sulfate infusion was initiated as a prophylactic measure to prevent seizures, while discussions about potential early delivery were initiated with the patient and her family. The interdisciplinary team prepared for possible maternal and neonatal complications, highlighting the need for continued vigilance and timely decision-making. This shift in the patient's status not only underscored the dynamic nature of preeclampsia but also emphasized the importance of comprehensive care and readiness to adapt treatment as the clinical scenario evolved.

Section 2

As the magnesium sulfate infusion progressed, the healthcare team closely monitored the patient's response to the intervention, particularly watching for signs of magnesium toxicity, such as respiratory depression or loss of deep tendon reflexes. Over the next few hours, the patient's blood pressure remained elevated, with readings consistently hovering around 160/105 mmHg, despite the escalation in pharmacological management. This prompted the team to consider adding a calcium channel blocker, such as nifedipine, to her regimen to achieve better blood pressure control.

Simultaneously, the patient's neurological symptoms appeared to stabilize with the magnesium sulfate, as she reported a slight improvement in her headache and no new visual disturbances. However, the tenderness in the right upper quadrant persisted, and repeat liver function tests showed further elevation of liver enzymes, while platelet counts continued to trend downwards, now just below the normal range. These laboratory findings reinforced the suspicion of HELLP syndrome, raising the urgency for potential delivery as part of the treatment plan.

The healthcare team engaged in another round of detailed discussions with the patient and her family, emphasizing the critical balance between prolonging the pregnancy for fetal maturity and mitigating the risks to maternal health. They considered administering corticosteroids to accelerate fetal lung maturity, given the likely need for preterm delivery. The plan included continued close monitoring of both maternal and fetal status, along with preparations for potential neonatal intensive care support. The evolving scenario highlighted the importance of dynamic, evidence-based decision-making and the need for collaborative care across the multidisciplinary team.

Section 3

As the healthcare team continued to monitor the patient, they noted a new development in her clinical status. The patient began to exhibit signs of increased respiratory effort, with a respiratory rate climbing to 26 breaths per minute and oxygen saturation levels slightly dropping to 92% on room air. This prompted an urgent assessment to rule out potential complications such as pulmonary edema, a known risk in preeclampsia due to increased vascular permeability and fluid retention. A bedside ultrasound was performed, revealing mild bilateral pleural effusions, suggesting the onset of pulmonary edema.

Concurrently, fetal monitoring indicated some concerning trends. The fetal heart rate tracing showed decreased variability and a few late decelerations, suggesting possible fetal distress. This necessitated immediate coordination with the obstetrics team to evaluate the need for imminent delivery, given the potential compromise to both maternal and fetal well-being. The decision-making process involved weighing the risks of preterm delivery against the deteriorating maternal condition.

In response to these developments, the healthcare team adjusted the patient's care plan. They implemented oxygen therapy to improve maternal oxygenation and reassessed fluid management strategies to address the potential pulmonary edema. Additionally, they expedited the administration of corticosteroids to enhance fetal lung maturity, preparing for the possibility of delivering the baby within the next 24 to 48 hours. These interventions underscored the critical need for vigilant monitoring and timely adjustments to the treatment plan, as the patient's condition continued to evolve.

Section 4

In the hours following the implementation of the updated care plan, the patient's condition showed mixed responses to the interventions. Oxygen therapy successfully stabilized her oxygen saturation levels, maintaining them around 95% on 2 liters of nasal cannula. However, her respiratory rate remained elevated at 24 breaths per minute, indicating ongoing respiratory effort. Despite this, the patient reported feeling slightly more comfortable and less short of breath, suggesting a partial improvement in her respiratory status.

On the fetal side, continuous monitoring showed persistent late decelerations with minimal variability, raising concerns about the adequacy of placental perfusion. The obstetrics team performed a biophysical profile, which resulted in a score of 6 out of 10, reflecting a need for close watch and potential intervention. The decision was made to initiate magnesium sulfate to provide neuroprotection for the fetus and to further manage the risk of seizures in the mother, as her blood pressure remained elevated at 160/105 mmHg despite antihypertensive therapy.

Meanwhile, new lab results revealed a rise in liver enzymes, with AST and ALT levels now at 85 and 92 U/L, respectively, and a decrease in platelet count to 95,000/µL, signaling the progression towards HELLP syndrome. These findings necessitated a multidisciplinary discussion on the timing of delivery to balance the risks to the mother and the fetus. Given the patient's evolving clinical picture, the healthcare team prepared for a possible delivery within the next 24 hours, emphasizing the importance of readiness for rapid intervention should further deterioration occur. This case underscored the need for ongoing critical assessment and dynamic decision-making to navigate the complex interplay of maternal and fetal health in preeclampsia.

Section 5

As the team continued to monitor the patient closely, a new complication emerged, adding further complexity to her condition. Approximately six hours after the initiation of magnesium sulfate, the patient began to exhibit signs of magnesium toxicity. Her deep tendon reflexes, previously brisk, became diminished to absent. She also reported experiencing nausea, flushing, and a sensation of warmth, which are early indicators of magnesium sulfate overdose. The team immediately assessed her magnesium levels, which returned at 9 mg/dL, confirming the suspicion of toxicity. This necessitated an urgent adjustment in the infusion rate and administration of calcium gluconate as an antidote to counteract the effects of the magnesium.

Concurrently, the fetal heart rate pattern became more concerning. The late decelerations persisted, and fetal heart rate variability decreased further, raising the suspicion of worsening placental insufficiency. A repeat biophysical profile indicated a score of 4 out of 10, signaling significant fetal distress. The obstetric team, in consultation with neonatology, recommended an expedited delivery to mitigate risks to both the mother and the fetus. Despite the magnesium toxicity, the decision was made to proceed with a cesarean section given the critical nature of the situation.

This development required the healthcare team to reassess their priorities swiftly and effectively. They had to balance the immediate need to resolve the magnesium toxicity while preparing for an urgent surgical intervention. The interdisciplinary team's ability to recognize and respond to the evolving complications in a timely manner was crucial to ensuring the best possible outcomes for both mother and child. This scenario highlights the necessity of continuous monitoring and the readiness to adapt treatment plans in response to rapidly changing clinical situations in the management of preeclampsia.